SOLIRIS 300 MG PERF FL 30 ML
(Eculizumab) - Médicament désigné comme "orphelin"
Treatment of adults and children with :
- paroxysmal nocturnal haemoglobinuria (PNH). Evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.
- atypical haemolytic uraemic syndrome (aHUS).